.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Decompression surgery for lumbar spinal stenosis is often discussed against a background of conservative care, but randomized evidence is important when counselling patients about the likely benefit. This multicentre randomized trial compared surgical decompression with a structured nonoperative strategy. Surgery produced greater improvement in pain and function over the study period, while nonoperative treatment still provided benefit for some patients. The trial illustrates that stenosis is not simply an imaging diagnosis: symptoms such as neurogenic claudication and functional limitation determine who is most likely to value decompression. For HCPs, the key clinical question is not whether surgery is universally superior, but whether the patient's symptom burden and functional goals justify operative risk. Conservative management can include education, exercise, analgesia and activity modification, but persistent disabling symptoms despite appropriate nonoperative care make decompression a reasonable option. The paper also supports careful patient selection and expectation setting. Surgery can improve walking and pain, but it does not reverse every degenerative change on imaging. A symptom-driven approach remains the most defensible way to integrate the evidence.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Decompression surgery for lumbar spinal stenosis is often discussed against a background of conservative care, but randomized evidence is important when counselling patients about the likely benefit. This multicentre randomized trial compared surgical decompression with a structured nonoperative strategy. Surgery produced greater improvement in pain and function over the study period, while nonoperative treatment still provided benefit for some patients. The trial illustrates that stenosis is not simply an imaging diagnosis: symptoms such as neurogenic claudication and functional limitation determine who is most likely to value decompression. For HCPs, the key clinical question is not whether surgery is universally superior, but whether the patient's symptom burden and functional goals justify operative risk. Conservative management can include education, exercise, analgesia and activity modification, but persistent disabling symptoms despite appropriate nonoperative care make decompression a reasonable option. The paper also supports careful patient selection and expectation setting. Surgery can improve walking and pain, but it does not reverse every degenerative change on imaging. A symptom-driven approach remains the most defensible way to integrate the evidence.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
